Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody

Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody

Introduction: Although immune checkpoint inhibitors (ICIs) have been considered as promising agents for the treatment of advanced hepatocellular carcinoma (HCC), previous clinical trials revealed that the response to anti-programmed cell death protein 1 (anti-PD-1) monotherapy was as low as 20%. Ide...

Full description

Bibliographic Details
Main Authors: Masahiro Morita, Naoshi Nishida, Kazuko Sakai, Tomoko Aoki, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Kazuto Nishio, Yukari Kobayashi, Kazuhiro Kakimi, Masatoshi Kudo
Format: Article
Language:English
Published: Karger Publishers 2021-06-01
Series:Liver Cancer
Subjects:
hepatocellular carcinoma
wnt/β-catenin pathway
immune checkpoint inhibitors
survival
immunological microenvironment
Online Access:https://www.karger.com/Article/FullText/516899

Internet

https://www.karger.com/Article/FullText/516899

Similar Items